市場調査レポート

商品コード

1587560

経鼻ドラッグ＆ワクチンデリバリーの市場規模、シェア、動向分析レポート：製品別、用量別、用途別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

Intranasal Drug And Vaccine Delivery Market Size, Share & Trends Analysis Report By Product, By Dosage (Deep Learning, Machine Learning), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2024年10月30日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

経鼻ドラッグ＆ワクチンデリバリー市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の経鼻ドラッグ＆ワクチンデリバリー市場規模は2030年までに1,033億3,000万米ドルに達すると推定され、2025～2030年にかけてCAGR 6.6%で成長する見込みです。

即効性を求めて非経口製剤や経口製剤よりも経鼻製剤を好む傾向が強まっていることが、市場を牽引する主要要因の1つです。

需要の増加と技術の進歩は主要な市場促進要因の一つです。研究開発への投資の増加は、様々な症状の治療に適応する臨床検査プログラムをエスカレートさせています。2020年3月、Auris Medical Holding Ltd.は、急性末梢性めまいの治療を目的とした経鼻ベタヒスチン（AM-125）のフェーズ2検査の最新情報を提供しました。

慢性呼吸器疾患の有病率の増加は、経鼻ドラッグ＆ワクチンデバイスの需要を増大させる。米国疾病予防管理センター（CDC）によると、2019年には13人に1人が喘息であり、2,500万人以上の米国人が喘息とともに生活しています。CDCはまた、喘息が年間推定1,420万件の病院受診、43万9,000件の病院退院、180万件の救急部受診を占めていると述べています。

液体送達デバイスは、水溶液、乳剤、懸濁液を含む様々な製剤で利用可能であることから、2019年の市場を独占しました。ユニットドセグメントは、様々な疾患の治療に対する承認の増加により、有利な成長が見込まれます。さらに、開発中のワクチン製剤の大半は単回投与製剤であり、医療関係者は1回分の経鼻ワクチン投与を一般的に推奨しています。

アジア太平洋は、予測期間中に最も急成長する地域市場になると予想されます。これは主に、製品開発プロトコルの増加、経済成長、新規ドラッグデリバリーシステムの開発に携わる現地市場参入企業の増加によるものです。

経鼻ドラッグデリバリーとワクチンデリバリー市場レポートハイライト

液体送達デバイスが2024年の売上高シェア43.7%で市場を独占。定量噴霧ポンプを含むこれらのデバイスは、初回通過代謝を回避し、バイオアベイラビリティを高め、治療効果を促進します。
複数回投与システムは、2024年の売上高シェア64.1％で市場をリードしています。複数回投与システムは耐性と利便性を向上させ、患者が少ない補充量で薬剤を自己投与できるようにします。
呼吸器疾患は、喘息、COPD、アレルギー性鼻炎などの症状に対する経鼻投与の有効性により、2024年に41.1%の最大市場シェアを占めました。
小売薬局が市場を独占し、2024年には45.1%のシェアを占めました。これは、患者の意識の高まりと、薬剤の自己投与への動向の高まりに後押しされたものです。

地域別市場シェア分析、2024年と2030年
地域別市場ダッシュボード
市場規模、予測動向分析、2018～2030年
北米
- 国別、2018～2030年
- 米国
- カナダ
- メキシコ
欧州
- 国別、2018～2030年
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- デンマーク
- スウェーデン
アジア太平洋
- 国別、2018～2030年
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- タイ
ラテンアメリカ
- 国別、2018～2030年
- ブラジル
- アルゼンチン
中東・アフリカ
- 国別、2018～2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

参加者概要
企業の市況分析
企業分類
戦略マッピング
企業プロファイル/上場企業
- GSK plc
- Teva Pharmaceutical Industries Ltd
- AptarGroup, Inc.
- UCB SA, Belgium
- Teleflex Incorporated
- 3M
- Bespak Limited
- Optinose
- Intersect ENT

図表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global intranasal drug and vaccine delivery market, by region, 2018 - 2030 (USD Million)
Table 4 Global intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 5 Global intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 6 Global intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 7 Global intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 North America intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 9 North America intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 10 North America intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 11 North America intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 12 North America intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 U.S intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 14 U.S intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 15 U.S intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 16 U.S intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 17 Canada intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 18 Canada intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 19 Canada intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 20 Canada intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 21 Mexico intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 22 Mexico intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 23 Mexico intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 24 Mexico intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Europe intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 26 Europe intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 27 Europe intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 28 Europe intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 29 Europe intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 UK intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 31 UK intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 32 UK intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 33 UK intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 34 Germany intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 35 Germany intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 36 Germany intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 37 Germany intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 38 France intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 39 France intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 40 France intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 41 France intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 42 Italy intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 43 Italy intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 44 Italy intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 45 Italy intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Spain intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 47 Spain intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 48 Spain intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 49 Spain intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Denmark intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 51 Denmark intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 52 Denmark intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 53 Denmark intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 54 Sweden intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 55 Sweden intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 56 Sweden intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 57 Sweden intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 58 Norway intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 59 Norway intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 60 Norway intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 61 Norway intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 Asia Pacific intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 64 Asia Pacific intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 65 Asia Pacific intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 66 Asia Pacific intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 67 China intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 68 China intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 69 China intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 70 China intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 Japan intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 72 Japan intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 73 Japan intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 74 Japan intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 India intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 76 India intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 77 India intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 78 India intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 79 Australia intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 80 Australia intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 81 Australia intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 82 Australia intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 83 South Korea intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 84 South Korea intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 85 South Korea intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 86 South Korea intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 87 Thailand intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 88 Thailand intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 89 Thailand intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 90 Thailand intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 Latin America intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 92 Latin America intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 93 Latin America intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 94 Latin America intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 95 Latin America intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 Brazil intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 97 Brazil intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 98 Brazil intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 99 Brazil intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 100 Argentina intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 102 Argentina intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 103 Argentina intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 109 South Africa intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 111 South Africa intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 112 South Africa intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 117 UAE intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 118 UAE intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 119 UAE intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 120 UAE intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
Table 121 Kuwait intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
Table 123 Kuwait intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
Table 124 Kuwait intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Intranasal drug and vaccine delivery market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product and dosage outlook (USD Million)
Fig. 10 Application and distribution channel outlook
Fig. 11 Competitive landscape
Fig. 12 Intranasal drug and vaccine delivery market dynamics
Fig. 13 Intranasal drug and vaccine delivery market: Porter's five forces analysis
Fig. 14 Intranasal drug and vaccine delivery market: PESTLE analysis
Fig. 15 Intranasal drug and vaccine delivery market: Product segment dashboard
Fig. 16 Intranasal drug and vaccine delivery market: Product market share analysis, 2024 & 2030
Fig. 17 Powder delivery device market, 2018 - 2030 (USD Million)
Fig. 18 Liquid delivery device (metered spray pumps) market, 2018 - 2030 (USD Million)
Fig. 19 Pressurized metered dose inhaler market, 2018 - 2030 (USD Million)
Fig. 20 Others market, 2018 - 2030 (USD Million)
Fig. 21 Intranasal drug and vaccine delivery market: Dosage segment dashboard
Fig. 22 Intranasal drug and vaccine delivery market: Dosage market share analysis, 2024 & 2030
Fig. 23 Unit-dose market, 2018 - 2030 (USD Million)
Fig. 24 Multi-dose market, 2018 - 2030 (USD Million)
Fig. 25 Intranasal drug and vaccine delivery market: Application segment dashboard
Fig. 26 Intranasal drug and vaccine delivery market: Application market share analysis, 2024 & 2030
Fig. 27 Respiratory disorders market, 2018 - 2030 (USD Million)
Fig. 28 Neurological disorders market, 2018 - 2030 (USD Million)
Fig. 29 Vaccination market, 2018 - 2030 (USD Million)
Fig. 30 Pain management market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Intranasal drug and vaccine delivery market: Distribution channel segment dashboard
Fig. 33 Intranasal drug and vaccine delivery market: Distribution channel market share analysis, 2024 & 2030
Fig. 34 Hospital pharmacies market, 2018 - 2030 (USD Million)
Fig. 35 Retail pharmacies market, 2018 - 2030 (USD Million)
Fig. 36 Online pharmacies market, 2018 - 2030 (USD Million)
Fig. 37 Intranasal drug and vaccine delivery market revenue, by region
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 North America intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 41 U.S. country dynamics
Fig. 42 U.S. intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 43 Canada country dynamics
Fig. 44 Canada intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 45 Mexico country dynamics
Fig. 46 Mexico intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 47 Europe intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 48 UK country dynamics
Fig. 49 UK intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 50 Germany country dynamics
Fig. 51 Germany intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 52 France country dynamics
Fig. 53 France intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 54 Italy country dynamics
Fig. 55 Italy intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 56 Spain country dynamics
Fig. 57 Spain intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 58 Norway country dynamics
Fig. 59 Norway intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 60 Sweden country dynamics
Fig. 61 Sweden intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 62 Denmark country dynamics
Fig. 63 Denmark intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 64 Asia Pacific intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 65 Japan country dynamics
Fig. 66 Japan intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 67 China country dynamics
Fig. 68 China intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 69 India country dynamics
Fig. 70 India intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 71 Australia country dynamics
Fig. 72 Australia intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 73 South Korea country dynamics
Fig. 74 South Korea intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 75 Thailand country dynamics
Fig. 76 Thailand intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 77 Latin America intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 78 Brazil country dynamics
Fig. 79 Brazil intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 80 Argentina country dynamics
Fig. 81 Argentina intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 82 MEA intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 83 South Africa country dynamics
Fig. 84 South Africa intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 85 Saudi Arabia country dynamics
Fig. 86 Saudi Arabia intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 87 UAE country dynamics
Fig. 88 UAE intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 89 Kuwait country dynamics
Fig. 90 Kuwait intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
Fig. 91 Company categorization
Fig. 92 Company market position analysis
Fig. 93 Strategic framework

Product Code: GVR-4-68038-479-6

Intranasal Drug And Vaccine Delivery Market Growth & Trends:

The global intranasal drug and vaccine delivery market size is estimated to reach USD 103.33 billion by 2030, registering to grow at a CAGR of 6.6% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing preference for nasal products over parenteral and oral formulations for instant relief is one of the major factors driving the market.

Increasing demand and advancements in technology are some of the major market drivers. Rising investment in research and development has escalated the clinical trial programs indicated for the treatment of various conditions. In March 2020, Auris Medical Holding Ltd. provided the Phase 2 trial update for intranasal betahistine (AM-125) for the treatment of acute peripheral vertigo.

Increasing prevalence of chronic respiratory disorders augments the demand for intranasal drug and vaccine devices as they are commonly prescribed by medical professionals owing to the easy self-administration technique. According to the Centers for Disease Control and Prevention (CDC), in 2019, 1 in 13 people have asthma, with more than 25 million Americans living with asthma. CDC also stated that asthma accounted for an estimated 14.2 million hospital visits, 439,000 hospital discharges, and 1.8 million emergency department visits annually.

Liquid delivery devices dominated the market in 2019 on account of their availability in various formulations, including aqueous solutions, emulsions, and suspensions. The unit-does segment is anticipated to witness lucrative growth due to increasing approvals for the treatment of various disorders. Moreover, majority of the vaccine formulations under development are unit-dose formulations as single intranasal vaccine dose is commonly recommended by medical professionals.

Asia Pacific is expected to emerge as the fastest growing regional market over the forecast period. This is primarily attributed to increasing product development protocols, economic growth, and increase in the number of local market players involved in the development of novel drug delivery systems.

Intranasal Drug And Vaccine Delivery Market Report Highlights:

Liquid delivery devices dominated the market with a revenue share of 43.7% in 2024. These devices, including metered spray pumps, circumvent first-pass metabolism, enhancing bioavailability and accelerating therapeutic effects.
Multi-dose systems led the market with a revenue share of 64.1% in 2024. Multi-dose systems provide improved tolerance and convenience, enabling patients to self-administer medications with fewer refills.
Respiratory disorders held the largest market share of 41.1% in 2024, owing to the efficacy of intranasal delivery for conditions such as asthma, COPD, and allergic rhinitis.
Retail pharmacies dominated the market and accounted for a share of 45.1% in 2024, fueled by rising patient awareness and a growing trend towards self-administration of medications.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Dosage
- 1.2.3. Application
- 1.2.4. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Intranasal Drug and Vaccine Delivery Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Intranasal Drug and Vaccine Delivery Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Powder Delivery Device
- 4.4.1. Powder Delivery Device Market, 2018 - 2030 (USD Million)
4.5. Liquid Delivery Device (Metered Spray Pumps)
- 4.5.1. Liquid Delivery Device (Metered Spray Pumps) Market, 2018 - 2030 (USD Million)
4.6. Pressurized Metered Dose Inhaler
- 4.6.1. Pressurized Metered Dose Inhaler Market, 2018 - 2030 (USD Million)
4.7. Others
- 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Intranasal Drug and Vaccine Delivery Market: Dosage Business Analysis

5.1. Dosage Market Share, 2024 & 2030
5.2. Dosage Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Dosage, 2018 to 2030 (USD Million)
5.4. Unit-dose
- 5.4.1. Unit-dose Market, 2018 - 2030 (USD Million)
5.5. Multi-dose
- 5.5.1. Multi-dose Market, 2018 - 2030 (USD Million)

Chapter 6. Intranasal Drug and Vaccine Delivery Market: Application Business Analysis

6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Respiratory Disorders
- 6.4.1. Respiratory Disorders Market, 2018 - 2030 (USD Million)
6.5. Neurological Disorders
- 6.5.1. Neurological Disorders Market, 2018 - 2030 (USD Million)
6.6. Vaccination
- 6.6.1. Vaccination Market, 2018 - 2030 (USD Million)
6.7. Pain Management
- 6.7.1. Pain Management Market, 2018 - 2030 (USD Million)
6.8. Others
- 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Intranasal Drug and Vaccine Delivery Market: Distribution Channel Business Analysis

7.1. Distribution Channel Market Share, 2024 & 2030
7.2. Distribution Channel Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
7.4. Hospital Pharmacies
- 7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
7.5. Retail Pharmacies
- 7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
7.6. Online Pharmacies
- 7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 8. Intranasal Drug and Vaccine Delivery Market: Regional Estimates & Trend Analysis by Product, Dosage, Application, and Distribution Channel

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Regulatory Framework
  - 8.4.2.3. Competitive Insights
  - 8.4.2.4. U.S. Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Regulatory Framework
  - 8.4.3.3. Competitive Insights
  - 8.4.3.4. Canada Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Regulatory Framework
  - 8.4.4.3. Competitive Insights
  - 8.4.4.4. Mexico Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Regulatory Framework
  - 8.5.2.3. Competitive Insights
  - 8.5.2.4. UK Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Regulatory Framework
  - 8.5.3.3. Competitive Insights
  - 8.5.3.4. Germany Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Regulatory Framework
  - 8.5.4.3. Competitive Insights
  - 8.5.4.4. France Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Regulatory Framework
  - 8.5.5.3. Competitive Insights
  - 8.5.5.4. Italy Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Regulatory Framework
  - 8.5.6.3. Competitive Insights
  - 8.5.6.4. Spain Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Regulatory Framework
  - 8.5.7.3. Competitive Insights
  - 8.5.7.4. Norway Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key Country Dynamics
  - 8.5.8.2. Regulatory Framework
  - 8.5.8.3. Competitive Insights
  - 8.5.8.4. Denmark Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Sweden
  - 8.5.9.1. Key Country Dynamics
  - 8.5.9.2. Regulatory Framework
  - 8.5.9.3. Competitive Insights
  - 8.5.9.4. Sweden Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Regulatory Framework
  - 8.6.2.3. Competitive Insights
  - 8.6.2.4. Japan Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Regulatory Framework
  - 8.6.3.3. Competitive Insights
  - 8.6.3.4. China Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Regulatory Framework
  - 8.6.4.3. Competitive Insights
  - 8.6.4.4. India Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Regulatory Framework
  - 8.6.5.3. Competitive Insights
  - 8.6.5.4. South Korea Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Regulatory Framework
  - 8.6.6.3. Competitive Insights
  - 8.6.6.4. Australia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key Country Dynamics
  - 8.6.7.2. Regulatory Framework
  - 8.6.7.3. Competitive Insights
  - 8.6.7.4. Thailand Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Regulatory Framework
  - 8.7.2.3. Competitive Insights
  - 8.7.2.4. Brazil Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Regulatory Framework
  - 8.7.3.3. Competitive Insights
  - 8.7.3.4. Argentina Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Regulatory Framework
  - 8.8.2.3. Competitive Insights
  - 8.8.2.4. South Africa Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Regulatory Framework
  - 8.8.3.3. Competitive Insights
  - 8.8.3.4. Saudi Arabia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Regulatory Framework
  - 8.8.4.3. Competitive Insights
  - 8.8.4.4. UAE Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key Country Dynamics
  - 8.8.5.2. Regulatory Framework
  - 8.8.5.3. Competitive Insights
  - 8.8.5.4. Kuwait Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
- 9.5.1. GSK plc
  - 9.5.1.1. Overview
  - 9.5.1.2. Financial Performance
  - 9.5.1.3. Product Benchmarking
  - 9.5.1.4. Strategic Initiatives
- 9.5.2. Teva Pharmaceutical Industries Ltd
  - 9.5.2.1. Overview
  - 9.5.2.2. Financial Performance
  - 9.5.2.3. Product Benchmarking
  - 9.5.2.4. Strategic Initiatives
- 9.5.3. AptarGroup, Inc.
  - 9.5.3.1. Overview
  - 9.5.3.2. Financial Performance
  - 9.5.3.3. Product Benchmarking
  - 9.5.3.4. Strategic Initiatives
- 9.5.4. UCB S.A., Belgium
  - 9.5.4.1. Overview
  - 9.5.4.2. Financial Performance
  - 9.5.4.3. Product Benchmarking
  - 9.5.4.4. Strategic Initiatives
- 9.5.5. Teleflex Incorporated
  - 9.5.5.1. Overview
  - 9.5.5.2. Financial Performance
  - 9.5.5.3. Product Benchmarking
  - 9.5.5.4. Strategic Initiatives
- 9.5.6. 3M
  - 9.5.6.1. Overview
  - 9.5.6.2. Financial Performance
  - 9.5.6.3. Product Benchmarking
  - 9.5.6.4. Strategic Initiatives
- 9.5.7. Bespak Limited
  - 9.5.7.1. Overview
  - 9.5.7.2. Financial Performance
  - 9.5.7.3. Product Benchmarking
  - 9.5.7.4. Strategic Initiatives
- 9.5.8. Optinose
  - 9.5.8.1. Overview
  - 9.5.8.2. Financial Performance
  - 9.5.8.3. Product Benchmarking
  - 9.5.8.4. Strategic Initiatives
- 9.5.9. Intersect ENT
  - 9.5.9.1. Overview
  - 9.5.9.2. Financial Performance
  - 9.5.9.3. Product Benchmarking
  - 9.5.9.4. Strategic Initiatives

経鼻ドラッグ＆ワクチンデリバリーの市場規模、シェア、動向分析レポート：製品別、用量別、用途別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

Intranasal Drug And Vaccine Delivery Market Size, Share & Trends Analysis Report By Product, By Dosage (Deep Learning, Machine Learning), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

経鼻ドラッグ＆ワクチンデリバリー市場の成長と動向

経鼻ドラッグデリバリーとワクチンデリバリー市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章経鼻ドラッグ＆ワクチンデリバリー市場の変数、動向、範囲

第4章経鼻ドラッグ＆ワクチンデリバリー市場：製品ビジネス分析

第5章経鼻ドラッグ＆ワクチンデリバリー市場：用量ビジネス分析

第6章経鼻ドラッグ＆ワクチンデリバリー市場：用途ビジネス分析

第7章経鼻ドラッグ＆ワクチンデリバリー市場：流通チャネルビジネス分析

第8章経鼻ドラッグ＆ワクチンデリバリー市場：製品、用量、用途、流通チャネル別の地域別、推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Intranasal Drug And Vaccine Delivery Market Growth & Trends:

Intranasal Drug And Vaccine Delivery Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Intranasal Drug and Vaccine Delivery Market Variables, Trends, & Scope

Chapter 4. Intranasal Drug and Vaccine Delivery Market: Product Business Analysis

Chapter 5. Intranasal Drug and Vaccine Delivery Market: Dosage Business Analysis

Chapter 6. Intranasal Drug and Vaccine Delivery Market: Application Business Analysis

Chapter 7. Intranasal Drug and Vaccine Delivery Market: Distribution Channel Business Analysis

Chapter 8. Intranasal Drug and Vaccine Delivery Market: Regional Estimates & Trend Analysis by Product, Dosage, Application, and Distribution Channel

Chapter 9. Competitive Landscape

経鼻ドラッグ＆ワクチンデリバリーの市場規模、シェア、動向分析レポート：製品別、用量別、用途別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

Intranasal Drug And Vaccine Delivery Market Size, Share & Trends Analysis Report By Product, By Dosage (Deep Learning, Machine Learning), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

経鼻ドラッグ＆ワクチンデリバリー市場の成長と動向

経鼻ドラッグデリバリーとワクチンデリバリー市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経鼻ドラッグ＆ワクチンデリバリー市場の変数、動向、範囲

第4章 経鼻ドラッグ＆ワクチンデリバリー市場：製品ビジネス分析

第5章 経鼻ドラッグ＆ワクチンデリバリー市場：用量ビジネス分析

第6章 経鼻ドラッグ＆ワクチンデリバリー市場：用途ビジネス分析

第7章 経鼻ドラッグ＆ワクチンデリバリー市場：流通チャネルビジネス分析

第8章 経鼻ドラッグ＆ワクチンデリバリー市場：製品、用量、用途、流通チャネル別の地域別、推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Intranasal Drug And Vaccine Delivery Market Growth & Trends:

Intranasal Drug And Vaccine Delivery Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Intranasal Drug and Vaccine Delivery Market Variables, Trends, & Scope

Chapter 4. Intranasal Drug and Vaccine Delivery Market: Product Business Analysis

Chapter 5. Intranasal Drug and Vaccine Delivery Market: Dosage Business Analysis

Chapter 6. Intranasal Drug and Vaccine Delivery Market: Application Business Analysis

Chapter 7. Intranasal Drug and Vaccine Delivery Market: Distribution Channel Business Analysis

Chapter 8. Intranasal Drug and Vaccine Delivery Market: Regional Estimates & Trend Analysis by Product, Dosage, Application, and Distribution Channel

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章経鼻ドラッグ＆ワクチンデリバリー市場の変数、動向、範囲

第4章経鼻ドラッグ＆ワクチンデリバリー市場：製品ビジネス分析

第5章経鼻ドラッグ＆ワクチンデリバリー市場：用量ビジネス分析

第6章経鼻ドラッグ＆ワクチンデリバリー市場：用途ビジネス分析

第7章経鼻ドラッグ＆ワクチンデリバリー市場：流通チャネルビジネス分析

第8章経鼻ドラッグ＆ワクチンデリバリー市場：製品、用量、用途、流通チャネル別の地域別、推定・動向分析

第9章競合情勢